Racétam (French Wikipedia)

Analysis of information sources in references of the Wikipedia article "Racétam" in French language version.

refsWebsite

Global rank French rank

6doi.org

2^nd place

3^rd place

5nih.gov

4^th place

12^th place

doi.org

dx.doi.org

« Piracetam and levetiracetam, two pyrrolidone derivatives, exert antidystonic activity in a hamster model of paroxysmal dystonia », European Journal of Pharmacology, vol. 391, n^o 3,‎ mars 2000, p. 251–4 (PMID 10729365, DOI 10.1016/S0014-2999(00)00105-9)
« Design and study of piracetam-like nootropics, controversial members of the problematic class of cognition-enhancing drugs », Current Pharmaceutical Design, vol. 8, n^o 2,‎ 2002, p. 125–38 (PMID 11812254, DOI 10.2174/1381612023396582)
« Piracetam defines a new binding site for allosteric modulators of alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid (AMPA) receptors », Journal of Medicinal Chemistry, vol. 53, n^o 5,‎ mars 2010, p. 2197–203 (PMID 20163115, PMCID 2872987, DOI 10.1021/jm901905j)
« Nootropic drugs positively modulate alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid-sensitive glutamate receptors in neuronal cultures », Journal of Neurochemistry, vol. 58, n^o 4,‎ avril 1992, p. 1199–204 (PMID 1372342, DOI 10.1111/j.1471-4159.1992.tb11329.x)
« Novel positive allosteric modulators of sigma-1 receptor », SpringerPlus, vol. 4,‎ 2015, P51 (DOI 10.1186/2193-1801-4-S1-P51) :
« The R-configuration enantiomers of methylphenylpiracetam are more active positive allosteric modulators of Sigma-1 receptor than S-configuration enantiomers. »
« Profound effects of combining choline and piracetam on memory enhancement and cholinergic function in aged rats », Neurobiology of Aging, vol. 2, n^o 2,‎ 1981, p. 105–11 (PMID 7301036, DOI 10.1016/0197-4580(81)90007-5)

nih.gov

ncbi.nlm.nih.gov

« Piracetam and levetiracetam, two pyrrolidone derivatives, exert antidystonic activity in a hamster model of paroxysmal dystonia », European Journal of Pharmacology, vol. 391, n^o 3,‎ mars 2000, p. 251–4 (PMID 10729365, DOI 10.1016/S0014-2999(00)00105-9)
« Design and study of piracetam-like nootropics, controversial members of the problematic class of cognition-enhancing drugs », Current Pharmaceutical Design, vol. 8, n^o 2,‎ 2002, p. 125–38 (PMID 11812254, DOI 10.2174/1381612023396582)
« Piracetam defines a new binding site for allosteric modulators of alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid (AMPA) receptors », Journal of Medicinal Chemistry, vol. 53, n^o 5,‎ mars 2010, p. 2197–203 (PMID 20163115, PMCID 2872987, DOI 10.1021/jm901905j)
« Nootropic drugs positively modulate alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid-sensitive glutamate receptors in neuronal cultures », Journal of Neurochemistry, vol. 58, n^o 4,‎ avril 1992, p. 1199–204 (PMID 1372342, DOI 10.1111/j.1471-4159.1992.tb11329.x)
« Profound effects of combining choline and piracetam on memory enhancement and cholinergic function in aged rats », Neurobiology of Aging, vol. 2, n^o 2,‎ 1981, p. 105–11 (PMID 7301036, DOI 10.1016/0197-4580(81)90007-5)